The role of ras genes in the neoplasmic transformation in animals

Polish Journal of Veterinary Sciences

Volumn 7, Issue 1, 2004, Pages 47-52

  Rotkiewicz, T ^a   Slodki S ^a   Otrocka Domagala I ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Cell transformation; Mutation; Ras genes

Indexed keywords

CARCINOGENESIS; CELL TRANSFORMATION; CODON; GENE ACTIVATION; GENE MUTATION; NONHUMAN; ONCOGENE RAS; POINT MUTATION; PROTO ONCOGENE; REVIEW;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; MUTATION; NEOPLASMS;

ANIMALIA;

EID: 1642387218     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Aldaz CM, Chen A, Gollahon LS, Russo J, Zappler K (1992) Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression. Cancer Res 52: 4791-1798.
2. Aldaz CM, Gollahon LS, Chen A (1993) Systematic HRAS amplification in ovary-independent mammary tumors: correlation with progressively anaplastic phenotypes. Cancer Res 53: 5339-5344.
3. Balmain A, Brown K (1988) Oncogene activation in chemical carcinogenesis. Adv Cancer Res 51: 147-182.
4. Barbacid M (1987) Ras genes. Annu Rev Biochem. 56: 779-827.
5. Barbacid M (1990) Ras oncogenes: their role in neoplasia. Europ J Clin Invest 20: 225-235.
6. Bos JL (1989) Ras oncogenes in human cancer. Cancer Res 49: 4682-4689.
7. Braun RJ, Pezzuto JM, Anderson CH, Beattie CW (1989) Estrous cycle status alters N-methyl-N-nitrosourea (NMU)-induced rat mammary tumor growth and regression. Cancer Lett 48: 205-211.
8. Calvert RJ, Ramakrishna G, Tepper S, Diwan BA, Anderson LM, Kritchevsky D (2002) Alterations in membrane-bound and cytoplasmic K-ras protein levels in mouse lung induced by treatment with lovastatin, cholestyramine, or niacin: effects are highly mouse strain dependent. Biochem Pharmacol 64: 41-48.
9. Castagnaro M (1995) Ras gene analysis in mammary tumors of dogs by means of PCR-SSCP and direct genomic analysis. Annali dell'Istitutio Superiore di Sanita (Roma) 31: 337-341.
10. Chora̧ży M, Szala S (1996) Udział genów w procesie nowotworzenia. In: Wȩgleński P (ed) Genetyka molekularna. Wydawnistwo Naukowe PWN, Warszawa, pp 385-410.
11. Cooper GM (1995) Cellular oncogenes and tumor suppressor genes. In: Cooper GM (2nd ed) Oncogenes. Jones and Bartlett, Sudbury, pp 174.
12. Dulbecco R, Armstrong B (1988) Stochastic development of invasive potential in rat mammary tumors induced by N-methyl-N-nitrosourea. Proc Natl Acad Sci USA 85: 8659-8663.
13. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med 312: 146-151.
14. Edwards MD, Pazzi KA, Gumerlock PH, Madewell BR (1993) c-N-ras is activated infrequently in canine malignant lymphoma. Toxicol Pathol 21(3): 288-291.
15. Freitas RN, Brasileiro-Filho G, Silva ME, Pena SDJ (2002) Bracken fern-induced malignant tumors in rats: absence of mutations in p53, H-ras and K-ras and no microsatellite instability. Mutation Research 499: 189-196.
16. Griffey SM, Kraegel SA, Madewell BR (1998) Rapid detection of K-ras mutations in canine lung cancer using single-strand conformational polymorphism analysis. Carcinogenesis 19: 959-963.
17. Gullick WJ (1990) Growth factors and oncogenes in breast cancer. Progr Growth Factor Res 2:1-13.
18. Gullino PM, Pettigrew HM, Grantham FM (1975) N-Nitroso-methylurea, a mammary gland carcinogen in rats. J Natl Cancer Inst 54: 404-414.
19. Guzman RC, Osborn RC, Bartley JC, Nandi S (1988) Metabolism of 7.12-dimethylbenz(a)anthracene by mouse mammary epithelial cells cultured serum-free inside collagen gels. Cancer Lett 40: 123-132.
20. Haslam SZ, Bern HA (1977) Histopathogenesis of 7.12-dimethylbenz(a) anthracene-induced rat mammary tumors. Proc Natl Acad Sci USA 74: 4020-4024.
21. Haubruck H, McCormick F (1991) Ras p21, effects and regulation. Biochim Biophys Acta 1072: 215-229.
22. Isaacs JT (1986) Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46: 3958-3963.
23. Jahn GA, Diolez-Bojda F, Belair L, Kerdelhue B, Kelly PA, Djiane J, Edery M (1991) Effect of DMBA on the expression of prolactin receptors and IGF1 genes in rat mammary gland. Biomed Pharmacother 45: 15-22.
24. Koenders PG, Beex LV, Langens R, Kloppenborg PW, Smals AG, Benraad TJ (1991) Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Cancer Res Treat 18: 27-32.
25. Kraegel SA, Gumerlock PH, Dungworth DL, Oreffo VI, Madewell BR (1992) K-ras activation in non-small cell lung cancer in the dog. Cancer Res 52: 4724-4727.
26. Kumar R, Sukumar S, Barbacid M (1990) Activation of ras oncogenes preceding the onset of neoplasia. Science 248: 1101-1104.
27. Lindsey WF, DasGupta TK, Beattie CW (1981) Influence of the estrous cycle on nitrosomethylurea-induced mammary carcinoma. Cancer Res 41: 3857-3862.
28. Lu SJ, Archer MC (1992) H-ras oncogene activation in mammary glands of N-methyl-N-nitrosourea-treated rats genetically resistant to mammary adenocarcinogenesis. Proc Natl Acad Sci USA 89: 1001-1005.
29. Madej JA (1996) Onkogeneza jako wynik zaburzenia struktury elektronowej DNA. In: Madej JA (ed) Etiologia i patogeneza nowotworów. Wydawnictwo h-medica press, Bielsko-Biała, pp 18-22.
30. Madej JA (1996) Udział czynników endogennych w indukcji nowotworów. In: Madej JA (ed) Etiologia i patogeneza nowotworów. Wydawnictwo α-medica press, Bielsko-Biała, pp 35-41.
31. Madej JA, Rotkiewicz T (1998) Czynniki onkogenne. In: Patologia ogólna zwierza̧t. Wydawnictwo ART, Olsztyn, pp 165-198.
32. Madej JA, Rotkiewicz T, Nozdryn-Płotnicki Z (2000) Patologia gruczołu mlekowego. In: Patologia szczegółowa zwierza̧t. Wydawnictwo UWM, Olsztyn, pp 478-486.
33. Matthews HR, Freedland RA, Miesfeld RL (2000) Onkogeny i rak. In: Biochemia i biologia molekularna w zarysie. Prószyński i S-ka, Warszawa, pp 481-500.
34. Mayr B, Dressler A, Reifinger M, Feil C (1998). Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. Am J Vet Res 59: 69-78.
35. Mayr B, Reifinger M, Brem G, Feil C, Schleger W (1999). Cytogenetic, ras, and p53: studies in cases of canine neoplasms (hemangiopericytoma, mastocytoma, histiocytoma, chloroma). The Journal of Heredity 90: 124-128.
36. Mayr B, Winkler G, Schaffner G, Reifinger M, Brem G (2002) N-ras mutation in a feline lymphoma. Low frequency of N-ras mutations in a series of feline, canine and bovine lymphomas. The Veterinary Journal 163: 326-328.
37. McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM (1990) How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82: 1006-1015
38. Olson MF, Marais R (2000) Ras protein signalling. Immunology 12: 63-73.
39. Quintanilla M, Brown K, Rarnsden M, Balmain H (1986) Carcinogen specific amplification of H-ras during mouse skin carcinogenesis. Nature 322: 7d8-80.
40. Rodenhcis S, Bos JL, Slater RM, Behrendt H, Van;T Veer M, Smets LA (1986) Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood 67: 1698-1704.
41. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A (1991) PRAD1, a candidate BCL1 oncogene, mapping and expression in controcytic lymphoma. Proc Natl Acad Sci USA 88: 9638-9642.
42. Sakai H, Ogawa K (1991) Mutational activation of c-Ha-ras genes in intraductal proliferation induced by N-nitroso-N-methylurea in rat mammary glands. Int J Cancer 49: 140-144.
43. Slingerland JM, Benchimol S (1991) Transforming activity of mutant human p53 alleles. J Cell Physiol 148: 391-395.
44. Steeg PS, Bevilequa G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta IA, Sobel ME (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204.
45. Sternberg PW, Han M (1998) Genetics of RAS signaling in C. elegans. Trends Genet 14: 466-472.
46. Sukumar S, Notario V, Martin-Zanca D, Barbacid M (1983) Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 306: 658-661.
47. Sukumar S, Carney WP, Barbacid M (1988) Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas. Science 240: 524-526.
48. Sukumar S (1989) Ras oncogenes in chemical carcinogenesis. Curr Topics Microbiol Immunol 148: 93-114.
49. Sukumar S, McKenzie K, Chen Y (1995) Animal models for breast cancer. Mutation Research 333: 37-44.
50. Tan PB, Kim SK (1999) Signaling specificity: the RTK/RAS/MAP kinase pathway in metazoans. Trends Genet 5: 145-149.
51. Taylor WR, Egan SE, Mowat M, Greenberg AH, Wright JA (1992) Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination. Oncogene 7: 1383-1390.
52. Teich NM (1997) Oncogenes and cancer oncogenes and cancer. In. Franks LM & Teich NM (3rd ed) Introduction to the cellular and molecular biology of cancer. Oxford University Press, Oxford, pp 181.
53. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL (1992) Induction by estrogen metabolite 16h-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 84: 634-638.
54. Watzinger F, Mayr B, Gamerith R, Vetter C, Lion T (2001) Comparative analysis of ras proto-oncogene mutations in selected mammalian tumors. Molecular Carcinogenesis 30: 190-198.
55. Yuspa SH, Poirier MC (1988) Chemical carcinogenesis: from animal models to molecular models in one decade. Adv Cancer Res 50: 25-70.
56. Zambon CF, Navaglia F, Basso D, Gallo N, Greco E, Piva MG, Fogar P, Pasquali C, Pedrazzoli S, Plebani M (2000) ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications. Clinica Chimica Acta 302: 35-48.
57. Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M (1985) Direct mutagenesis of H-ras-1 oncogenes by nitroso-methylurea during initiation of mammary carcinogenesis in rats. Nature 315: 382-385.